Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/20/2010EP2240506A1 Inhibitors of iap
10/20/2010EP2240505A1 Peptide for activating aquaporin synthesis
10/20/2010EP2240198A1 Composition for absorption through mucous tissue
10/20/2010EP2240197A2 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration
10/20/2010EP2240196A2 Clusterin derived peptide
10/20/2010EP2240194A1 Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
10/20/2010EP2240157A1 Ophthalmic preparations
10/20/2010EP2240155A2 Devices, formulations, and methods for delivery of multiple beneficial agents
10/20/2010EP2007417B1 Covalent factor vii-tissue factor complex
10/20/2010EP1989224B1 Immunogenic peptides and methods of use
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010EP1699759B1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/20/2010EP1608402B1 Improved vaccines
10/20/2010EP1407269B1 A method for diagnosing a person having multiple sclerosis
10/20/2010EP1383513B1 Tumor therapy with sindbis virus-based vectors
10/20/2010EP1373502B1 Dopaminergic neuronal survival-promoting factors and uses thereof
10/20/2010EP1360508B1 Prediction of wound healing by urinary nitrate assay
10/20/2010EP1282693B1 Human coagulation factor vii variants
10/20/2010EP1206554B2 Activatable recombinant neurotoxins
10/20/2010CN101868534A A method for identifying, expanding, and removing adult stem cells and cancer stem cells
10/20/2010CN101868476A Glucagon-like peptide-1 derivatives and their pharmaceutical use
10/20/2010CN101868475A Food material for inhibiting bone resorption
10/20/2010CN101868246A Targeted interferon demonstrates potent apoptotic and anti-tumor activities
10/20/2010CN101868245A An synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
10/20/2010CN101863985A Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer
10/20/2010CN101863982A Fusion protein for increasing blood platelets and preparation method thereof
10/20/2010CN101863971A Metastin derivatives and use thereof
10/20/2010CN101863965A Helicobacter pylori urease B antigenic epitope polypeptide and application thereof
10/20/2010CN101863964A Helicobacter pylori urease B antigen epitope polypeptide and application thereof
10/20/2010CN101863963A Helicobacter pylori antigen epitope polypeptide and application thereof
10/20/2010CN101863962A Polypeptide for inhibiting enzyme digestion of beta secretase and application thereof
10/20/2010CN101863958A Induction of the mitochondrial permeability transition
10/20/2010CN101862457A Degradable macromolecule carrier medicament as well as preparation method and application thereof
10/20/2010CN101862455A In-situ gelling drug delivery system
10/20/2010CN101862447A Natto kinase composition and preparation method thereof
10/20/2010CN101862446A SOD (Super Oxide Dismutase) grape health care wine
10/20/2010CN101862445A Oral insulin containing protease inhibitor
10/20/2010CN101862444A Application of interleukin 2 in preparing preparation for resisting prawn white spot syndrome virus
10/20/2010CN101862443A Preparation method of enramycin premix
10/20/2010CN101862350A Active ingredients of scorpion and application thereof
10/20/2010CN101862291A Bone induction gel
10/20/2010CN101244258B Use of TAT-N25 polypeptide in treating cell growth exception dermatosis such as psoriasis
10/20/2010CN101225106B Short peptide suppressing growth of cancer cell and uses thereof
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816506 Methods and constructs for producing transgenic plants and methods of recovering expressed proteins
10/19/2010US7816499 Antibody that binds histone deacetylase; transcription repressor activity and deacetylate cellular substrates; treatment of cell proliferation disease
10/19/2010US7816495 Processes for the preparation of fibrinogen
10/19/2010US7816494 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides; wound healing agents
10/19/2010US7816491 Ordered biological nanostructures formed from chaperonin polypeptides
10/19/2010US7816490 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT
10/19/2010US7816489 Methods for making intermediates and oxytocin analogues
10/19/2010US7816403 Administering a thiuram disulfide and a heavy metal ion; activated transcription factor/adenosine cyclic phosphate response element binding protein (atf/creb)
10/19/2010US7816402 Compositions and methods for the treatment of skin
10/19/2010US7816377 such as 1-methyl-piperidin-2-carbonsaure-[1-({1-[2-hydroxy-2-(4-phenethylcarbamoyl-thiazol-2-yl)-ethyl]-2-methyl-propyl}-methylcarbamoyl)-2-methyl-butyl]-amide, used for the treatement of adenocarcinoma
10/19/2010US7816336 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
10/19/2010US7816335 Therapeutic compounds and methods
10/19/2010US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines
10/19/2010US7816327 Topical administration for therapy of exposure to urushiol; irritating oils such as catechol-containing plant-derived antigens such as poison ivy, poison oak, poison sumac and Asian lacquer tree and oils containing capsaicin
10/19/2010US7816326 such as 2-Methyl-propane-2-sulfinic acid cyclohexylideneamide; coadministered with ribavirin, interferons
10/19/2010US7816325 secondary binding site of dipeptidyl peptidase IV, its relationship amongst substrates and to the modulation of substrate specificity of dipeptidyl peptidase IV (DP IV, synonym: DPP IV, CD26, EC 3.4.14.5). The application relates further to compounds that bind to the secondary binding site of DP IV
10/19/2010US7816324 Composition and method for the treatment of diseases affected by a peptide receptor
10/19/2010US7816323 coadministering bevacizumab, for treatment of breast cancer or colon cancer
10/19/2010US7816322 Stabilizing dystrophin associated protein complexes on cell surfaces; utilizing polypeptide related to amino acids 38-365 of sequence 9; muscular dystrophies; neuromuscular and neurological disorders
10/19/2010US7816321 treating skin lesions, heart injuries, corneal lesions and/or coronary heart disease
10/19/2010US7816320 point mutations with p-acetyl phenylalanine; covalently linked to poly(ethylene glycol); histidine buffer
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816318 emulsified nasal spray comprising macrocyclic permeation enhancer, liquid carrier comprising water, hydrocolloid emulsifying agent, and active agent other than insulin such as peptides, peptidomimetics, and proteins
10/19/2010US7816317 Tripeptide prodrug compounds
10/19/2010US7816316 hydrogel of hyaluronic acid derivative chemically crosslinked in solution in presence of pharmacologically active protein or peptide dissolved therein via dithiothreitol
10/19/2010US7816132 DNA encoding plexin polypeptides and kits thereof
10/19/2010US7816103 Protein having amino acid sequence in SEQ ID No.: 1 of the Sequence Listing derived from human MP52, and a dimer protein homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid; for treating cartilage and bone diseases
10/19/2010US7816097 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents
10/19/2010US7816091 Method of identifying a binding partner to a cytokine receptor common gamma chain like polypeptide
10/19/2010US7816086 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
10/19/2010US7816074 α4 β2 δGABA-A receptors as a strategy for PMS and alcoholism
10/19/2010US7815947 Nutritional composition for controlling blood sugar level
10/19/2010US7815943 Blood flow enhancer and inflamation reducer, anticholesterol agents and oxidation reduction
10/19/2010US7815941 Nucleic acid microspheres, production and delivery thereof
10/19/2010US7815921 Using patient's leukocyte concentration after incubation with colony stimulation factor as evaluative tool in predicting susceptibility to infection, bone marrow and autoimmune diseases after chemotherapeutic treatments
10/19/2010US7815918 Pneumococcal surface protein A for use in diagnosis, prevention and treatment of pneumocystis infection
10/19/2010US7815916 Using human T cell leukemia virus type III (HTLV-III) RNA to diagnose, treat and prevent infection by human aquired immunodeficiency virus; viricides
10/19/2010US7815912 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
10/19/2010US7815911 Compositions and methods for treating Yersinia pestis infection
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815902 Methods and compositions for cancer therapy using a novel adenovirus
10/19/2010US7815893 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/19/2010US7815686 tissue graft construct for repairing diseased or damaged tissues; comprising a matrix composition that has been seeded with vertebrate submucosa tissue, endothelial cells and at least one additional preselected exogenous population of cells; enhance the repair capabilities
10/19/2010CA2411590C Glycopeptide phosphonate derivatives
10/19/2010CA2400650C Compositions for preventing and treating digestive diseases
10/19/2010CA2397789C Novel human kinase protein and polynucleotides encoding the same
10/19/2010CA2390526C Sequence specific dna recombination in eukaryotic cells
10/19/2010CA2381489C G-csf analog compositions and methods
10/19/2010CA2376031C Product from starfish
10/19/2010CA2356845C Novel depsipeptide compound
10/19/2010CA2334914C Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
10/19/2010CA2325803C Novel omega conotoxin peptides
10/19/2010CA2309115C Use of cytokines and mitogens to inhibit pathological immune responses
10/19/2010CA2298412C Identification of human cell lines for the production of human proteins by endogenous gene activation
10/19/2010CA2286722C Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
10/19/2010CA2241179C Dry compositions
1 ... 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 ... 3163